Friday, October 9, 2015   

Convicted Korean scientist Hwang loses appeal
(02-27 17:05)

South Korea's apex court has upheld a suspended prison term on disgraced cloning scientist Hwang Woo Suk on criminal charges related to faked research.
A lower court in 2010 sentenced Hwang to 18 months in prison for embezzling research funds and illegally buying human eggs. But the court suspended the penalty.
The Supreme Court on Wednesday made that ruling final. He will stay free unless he breaks laws in the next two years.
Hwang scandalized the international scientific community in 2005 when his “breakthrough’’ human cloning research involving embryonic stem cells was found to have been faked.
Hwang and his former colleagues created the world's first cloned dog, Snuppy, in 2005, and that achievement was independently confirmed.—AP

Other World breaking news:
Nobel winner Alexievich says don’t give in to tyrants (10-08 22:08)
Swedes demolish stateless Palestinian camp (10-08 21:44)
Hungary calls in 1,000 EU, NATO troops to halt migrants (10-08 21:40)
Overwhelmed Europe hands return tickets to migrants (10-08 21:24)
33 missing after US bombing of MSF hospital (10-08 20:54)
Israeli soldier stabbed in Tel Aviv, attacker shot (10-08 20:50)
Nobel winner Svetlana Alexievich chronicles voices of pain (10-08 20:37)
Cambodia offers US$140 minimum wage for apparel workers (10-08 17:38)
Romania says refugee tide will provoke racists (10-08 17:35)
Kick the economic migrants out, Britain tells Europe (10-08 17:21)

More breaking news >>

© 2015 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2015, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.